Your session is about to expire
← Back to Search
HB0025 Injection for Cancer
Study Summary
This trial is testing a new drug, HB0025, for people with cancer who have no other treatment options. Up to 154 people will be enrolled. The trial will assess safety, how well the drug works, and side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
How many participants have been included in this clinical research?
"Affirmative. According to the info on clinicaltrials.gov, this experiment is currently recruiting volunteers and was originally posted on March 10th 2021 with an update made recently in May 31st 2022. A total of 154 participants are needed from one location."
What evidence is there that demonstrates the safety of HB0025 for individuals?
"Due to the minimal evidence regarding its efficacy and safety, HB0025 has been assigned a score of 1."
Are volunteers still welcome to participate in this testing program?
"According to the data available on clinicaltrials.gov, this research is currently looking for participants. It was initially published on March 10th 2021 and most recently revised on May 31st 2022."
Share this study with friends
Copy Link
Messenger